Medicinal cannabis has undergone a dramatic transformation, moving from a… stigmatised substance to a widely recognised treatment option for numerous health conditions. However, the path to legalisation has been far from uniform, with countries adopting different approaches.
A Brief History of Legalisation
Cannabis has been used medicinally for centuries, with evidence of its application in ancient China, India, and the Middle East. In the 20th century, prohibition led to its classification as an illegal substance in many parts of the world. However, the late 20th and early 21st centuries brought a shift in public perception and policy, as scientific research highlighted its therapeutic potential.
In 1996, California became the first U.S. state to legalise medicinal cannabis under Proposition 215.
Canada followed suit, legalising medicinal cannabis in 2001 and recreational use in 2018, making it a global leader in cannabis policy reform.
Germany legalised cannabis for medicinal use in 2017, allowing prescriptions for conditions such as chronic pain and multiple sclerosis.
Current Global Landscape
Today, over 50 countries permit medicinal cannabis use, but their regulatory frameworks vary significantly:
The United States
Although cannabis remains federally classified as a Schedule I drug, 38 states have legalised medicinal use. States like California and Colorado also permit recreational use, complicating the regulatory environment.
Europe
Nations such as the Netherlands and Portugal have progressive cannabis laws, while countries like France and Belgium are exploring pilot programmes.
Asia
Thailand is pioneering medicinal cannabis reform in the region, using it as an economic opportunity and health initiative.
Challenges in Legalisation
Despite progress, barriers persist:
Regulatory Complexity
Many countries face challenges in establishing consistent systems for cultivation, distribution, and patient access.
Public Stigma
Conservative attitudes and misinformation hinder acceptance in some areas.
Access and Affordability
Even in legal markets, high costs and restrictive eligibility criteria make access challenging for many patients.
Statistics
A report by Grand View Research valued the global medicinal cannabis market at £13.8 billion in 2022, projecting annual growth of 25.4% from 2023 to 2030.
According to Prohibition Partners, Germany is the largest medicinal cannabis market in Europe, with over 128,000 patients as of 2022.
